Trial NCT00863772

View at ClinicalTrials.gov 
Org. Study IDs: A4091026
Secondary IDs: NERVE SAFETY STUDY

Last trial update was posted on 2021-02-04

MeSH Interventions

Tanezumab

MeSH Conditions

Osteoarthritis

Other Conditions


Stopping Reasons

See termination reason in detailed description.

Limitations And Caveats

Due to US FDA imposed clinical hold (effective 23 June 2010), study was terminated early and planned sample size was not achieved. Due to change in planned analysis pre-specified outcome measure 'time to discontinuation due to lack of efficacy' was removed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID